 Visual Acuity
"Visual Acuity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Clarity or sharpness of OCULAR VISION or the ability of the eye to see fine details. Visual acuity depends on the functions of RETINA, neuronal transmission, and the interpretative ability of the brain. Normal visual acuity is expressed as 20/20 indicating that one can see at 20 feet what should normally be seen at that distance. Visual acuity can also be influenced by brightness, color, and contrast.
| Descriptor ID |
D014792
|
| MeSH Number(s) |
E01.370.380.850.950 F02.463.593.932.901 G14.940
|
| Concept/Terms |
Visual Acuity- Visual Acuity
- Acuities, Visual
- Acuity, Visual
- Visual Acuities
|
Below are MeSH descriptors whose meaning is more general than "Visual Acuity".
Below are MeSH descriptors whose meaning is more specific than "Visual Acuity".
This graph shows the total number of publications written about "Visual Acuity" by people in this website by year, and whether "Visual Acuity" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 3 | 3 | | 1996 | 0 | 2 | 2 | | 1997 | 0 | 2 | 2 | | 1998 | 2 | 1 | 3 | | 1999 | 0 | 3 | 3 | | 2000 | 0 | 2 | 2 | | 2001 | 1 | 2 | 3 | | 2003 | 1 | 3 | 4 | | 2004 | 0 | 1 | 1 | | 2005 | 1 | 2 | 3 | | 2006 | 3 | 5 | 8 | | 2007 | 0 | 4 | 4 | | 2008 | 0 | 6 | 6 | | 2009 | 1 | 1 | 2 | | 2010 | 0 | 3 | 3 | | 2011 | 0 | 5 | 5 | | 2012 | 0 | 5 | 5 | | 2013 | 1 | 2 | 3 | | 2014 | 1 | 4 | 5 | | 2015 | 0 | 6 | 6 | | 2016 | 3 | 7 | 10 | | 2017 | 0 | 3 | 3 | | 2018 | 6 | 7 | 13 | | 2019 | 7 | 6 | 13 | | 2020 | 9 | 7 | 16 | | 2021 | 2 | 2 | 4 | | 2022 | 0 | 6 | 6 | | 2023 | 1 | 6 | 7 | | 2024 | 6 | 5 | 11 | | 2025 | 1 | 2 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Visual Acuity" by people in Profiles.
-
Chen H, Strong Caldwell A, Patnaik JL, Feinstein EG, Ghiassi M, Mathias MT, Oliver SCN. LONG-TERM FUNCTIONAL AND CLINICAL OUTCOMES IN FAMILIAL EXUDATIVE VITREORETINOPATHY. Retina. 2025 May 01; 45(5):908-914.
-
Liu J, Edwards Mayhew RG, Imbornoni LM, Jung JL, Oliver SCN, Foreman NK, Mulcahy Levy JM, Hemenway M, McCourt EA. Pediatric MEK inhibitor-associated retinopathy: 8-year experience at a tertiary academic center and report of 2 cases. J AAPOS. 2025 Apr; 29(2):104178.
-
Hoskin AK, Sheng SNM, Blanch RJ, Giridhar A, Pauly M, Shah M, Sen A, Irawati Y, Pradhan E, Romero J, Agarwal M, Soleimani M, Grover AK, Mishra C, Ocampo HH, Khatri A, Bhalerao SA, Bhasin P, Ayachit A, Subramanian PS, Khandelwal R, Natarajan S, Sindal MD, Singh S, Fredrick T N, Zvornicanin J, Sundar G, Dalma-Weiszhausz J, Awan A, Ratra D, Bhatacharjee K, Choovuthayakorn J, Sharma S, Tawdekar Y, Jayadev C, Boesoirie SF, Rousselot AM, Rojas-Carabali W, Watson SL, Lee B, Agrawal R. Geographical differences in ophthalmic trauma outcomes and risk factors: the International Globe and Adnexal Trauma Epidemiological Eye Study (IGATES). Eye (Lond). 2025 Jun; 39(8):1532-1539.
-
Borchert GA, Kiire CA, Stone NM, Akil H, Gkika T, Fischer MD, Xue K, Cehajic-Kapetanovic J, MacLaren RE, Charbel Issa P, Downes SM, De Silva SR. Real-world six-month outcomes in patients switched to faricimab following partial response to anti-VEGF therapy for neovascular age-related macular degeneration and diabetic macular oedema. Eye (Lond). 2024 Dec; 38(18):3569-3577.
-
Wangyu S, Jung JL, Pecen PE, Palestine AG, Reddy AK. INTRAVITREAL 0.18-mg FLUOCINOLONE ACETONIDE IMPLANT FOR PEDIATRIC UVEITIS. Retina. 2024 10 01; 44(10):1823-1827.
-
Sundararajan M, Rathinam SR, Thundikandy R, Kanakath A, Balamurugan S, Vedhanayaki R, Miller DC, Lim LL, Suhler EB, Al-Dhibi HA, Arellanes-Garcia L, Reddy AK, Feng S, Doan T, Porco TC, Shantha JG, Acharya NR, Gonzales JA. Association Between Baseline Macular Morphologic Features on Optical Coherence Tomography and Visual Outcomes in Patients with Vogt-Koyanagi-Harada Disease. Ocul Immunol Inflamm. 2025 Feb; 33(2):263-270.
-
Sidhu S, Grove NC, Patnaik JL, Lynch AM, Christopher KL. Association Between Intraoperative Cataract Surgical Complications and Mortality. Ophthalmic Epidemiol. 2025 Jun; 32(3):334-340.
-
Cole ED, Dedania V, Demirci H. Occlusive Vasculitis Following Intravitreal Rituximab Injection for Primary Vitreoretinal Lymphoma. Ocul Immunol Inflamm. 2025 Jan; 33(1):161-165.
-
Hays RD, Tarver ME, Eydelman M, Spaeth GL, Parke DW, Singh K, Nguyen D, Saltzmann RM, Smith O, Shaw ML, Rosenberg L, Seibold L, Teymoorian S, Provencher LM, Bicket AK, Arora N, Junk AK, Chaya C, Salim S, Kuo D, Weiner A, Zhang Z, Rhee BFD, McMillan B, Choo C, Garris W, Noecker R, Fellman R, Caprioli J, Vold S, Pasquale L, Cui Q, Mbagwu M. A Health-Related Quality of Life Measure for Patients Who Undergo Minimally Invasive Glaucoma Surgery. Am J Ophthalmol. 2024 Oct; 266:313-320.
-
Lisker-Cervantes A, Gill Z, Gnanaraj R, Rajeswaren V, Mehta N, Gange B, Patnaik JL, Lynch AM, Palestine AG, Mathias M, Manoharan N, Mandava N, de Carlo Forest TE. Differences in imaging biomarkers between patients with intermediate and advanced non-neovascular age-related macular degeneration (AMD) in the University of Colorado AMD registry. Eur J Ophthalmol. 2025 Jan; 35(1):276-282.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|